Fluticasone-salmeterol 230-21 12GM
Ended Awarded
- Contract number
- SPE2DB26FY1S1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,392
Award facts
- Contract value 100% obligated
- $14,392.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,392.19 to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Fluticasone-Salmeterol 230-21 12GM, a combination corticosteroid and long-acting beta-agonist inhalant medication used in respiratory disease management. This firm fixed-price delivery order, with an ultimate completion date of October 31, 2025, represents a non-competitive, non-set-aside award to the prime contractor headquartered in Conshohocken, Pennsylvania. The order will be fulfilled from AmerisourceBergen's corporate office location in the same Pennsylvania municipality.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its established capability as a critical pharmaceutical vendor for the Defense Health Agency and other military healthcare systems, with consistent delivery of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FY1S1?
SPE2DB26FY1S1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FY1S1 worth?
The government has obligated $14,392 on SPE2DB26FY1S1.
Is contract SPE2DB26FY1S1 an order under another contract?
Yes. SPE2DB26FY1S1 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY1S1 competed?
The extent of competition for SPE2DB26FY1S1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award